Generation Bio (GBIO)
(Real Time Quote from BATS)
$4.37 USD
-0.19 (-4.17%)
Updated Aug 6, 2025 01:30 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GBIO 4.37 -0.19(-4.17%)
Will GBIO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GBIO
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Tops Revenue Estimates
GBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Gossamer Bio (GOSS) Reports Q4 Loss, Tops Revenue Estimates
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates
Vertex Pharmaceuticals (VRTX) Q3 Earnings and Revenues Top Estimates
Other News for GBIO
BlackRock, Inc. Reduces Stake in Generation Bio Co by 66.17%
Generation Bio (GBIO) Trading Halted Amid Pending Announcement | GBIO Stock News
Generation Bio trading halted, news pending
Generation Bio (GBIO) Announces 1-for-10 Reverse Stock Split | GBIO Stock News
Generation Bio Announces 1-for-10 Reverse Stock Split | GBIO Stock News